Pediatrik Epilepside Tedavi
Özet
Epilepsi, doğru tanı sonrası nöbet tipi ve sendrom özelliklerine göre farmakolojik tedavi, diyet, nörostimülasyon veya cerrahi yöntemlerle yönetilen, çocukluk çağında da sık görülen kronik bir nörolojik hastalıktır. İlaç tedavisine dirençli vakalarda, öncelikle ilaca dirençli epilepsi tanısı doğrulanmalı ve ardından uygun hastalar için epilepsi cerrahisi, ketojenik diyet veya nörostimülasyon seçenekleri değerlendirilmelidir. Çocuklarda cerrahi kararı, nöbet kontrolü ile birlikte bilişsel gelişim ve yaşam kalitesi ön planda tutularak, vakit kaybetmeden uzman merkezlerde multidisipliner yaklaşımla alınmalıdır.
Epilepsy is a common chronic neurological condition managed through pharmacological treatment, dietary interventions, neurostimulation, or surgery, depending on seizure type and syndromic classification after an accurate diagnosis. In drug-resistant cases, the diagnosis must first be confirmed, followed by the evaluation of epilepsy surgery, ketogenic diet, or neurostimulation for suitable patients. For children, surgical decisions should be made promptly in specialized multidisciplinary centers, prioritizing cognitive development and quality of life alongside seizure control.
Referanslar
Hirtz D, Thurman DJ, Gwinn-Hardy K, Mohamed M, Chaudhuri AR, Zalutsky R. How common are the "common" neurologic disorders? Neurology. 2007;68:326-37.
Cardarelli WJ, Smith BJ. The burden of epilepsy to patients and payers. Am J Manag Care. 2010;16:S331-6.
Serdaroglu A, Ozkan S, Aydin K, Gücüyener K, Tezcan S, Aycan S. Prevalence of Epilepsy in Turkish Children Between the Ages of 0 and 16 Years. Journal of Child Neurology. 2004;19:271-274.
Boon P, Ferrao Santos S, Jansen AC, Lagae L, Legros B, Weckhuysen S. Recommendations for the treatment of epilepsy in adult and pediatric patients in Belgium: 2020 update. Acta Neurol Belg. 2021;121:241-257.
Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51:1069-77.
Brodie MJ, Barry SJE, Bamagous GA, Norrie JD, Kwan P. Patterns of treatment response in newly diagnosed epilepsy. Neurology. 2012;78:1548-1554.
Sillanpää M, Jalava M, Kaleva O, Shinnar S. Long-term prognosis of seizures with onset in childhood. N Engl J Med. 1998;338:1715-22.
Alsfouk BA, Alsfouk AA, Chen Z, Kwan P, Brodie MJ. Pharmacological outcomes in teenagers with newly diagnosed epilepsy: A 30-year cohort study. Epilepsia. 2019;60:1083-1090.
Chen Z, Brodie MJ, Liew D, Kwan P. Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study. JAMA Neurol. 2018;75:279-286.
Wheless JW, Clarke DF, Arzimanoglou A, Carpenter D. Treatment of pediatric epilepsy: European expert opinion, 2007. Epileptic Disord. 2007;9:353-412.
Glauser T, Ben-Menachem E, Bourgeois B, et al. Updated ILAE evidence review of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia. 2013;54:551-63.
Lattanzi S, Zaccara G, Giovannelli F, et al. Antiepileptic monotherapy in newly diagnosed focal epilepsy. A network meta-analysis. Acta Neurol Scand. 2019;139:33-41.
Chen Z, Brodie MJ, Kwan P. What has been the impact of new drug treatments on epilepsy? Curr Opin Neurol. 2020;33:185-190.
Tomson T, Battino D, Bonizzoni E, et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol. 2018;17:530-538.
Kanner AM, Ashman E, Gloss D, et al. Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology. 2018;91:74-81.
Kwan P, Brodie MJ. Combination therapy in epilepsy: when and what to use. Drugs. 2006;66:1817-29.
Verrotti A, Tambucci R, Di Francesco L, et al. The role of polytherapy in the management of epilepsy: suggestions for rational antiepileptic drug selection. Expert Rev Neurother. 2020;20:167-173.
Brodie MJ, Sills GJ. Combining antiepileptic drugs--rational polytherapy? Seizure. 2011;20:369-75.
Moeller JJ, Rahey SR, Sadler RM. Lamotrigine-valproic acid combination therapy for medically refractory epilepsy. Epilepsia. 2009;50:475-9.
Pisani F, Oteri G, Russo MF, Di Perri R, Perucca E, Richens A. The efficacy of valproate-lamotrigine comedication in refractory complex partial seizures: evidence for a pharmacodynamic interaction. Epilepsia. 1999;40:1141-6.
Verrotti A, Lattanzi S, Brigo F, Zaccara G. Pharmacodynamic interactions of antiepileptic drugs: From bench to clinical practice. Epilepsy Behav. 2020;104:106939.
Moavero R, Santarone ME, Galasso C, Curatolo P. Cognitive and behavioral effects of new antiepileptic drugs in pediatric epilepsy. Brain Dev. 2017;39:464-469.
Egunsola O, Choonara I, Sammons HM. Safety of Levetiracetam in Paediatrics: A Systematic Review. PLoS One. 2016;11:e0149686.
Aldenkamp AP, Alpherts WC. The effect of the new antiepileptic drug rufinamide on cognitive functions. Epilepsia. 2006;47:1153-9.
Pressler RM, Binnie CD, Coleshill SG, Chorley GA, Robinson RO. Effect of lamotrigine on cognition in children with epilepsy. Neurology. 2006;66:1495-9.
Krauss GL, Klein P, Brandt C, et al. Safety and efficacy of adjunctive cenobamate (YKP3089) in patients with uncontrolled focal seizures: a multicentre, double-blind, randomised, placebo-controlled, dose-response trial. Lancet Neurol. 2020;19:38-48.
Devinsky O, Cilio MR, Cross H, et al. Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia. 2014;55:791-802.
Wheless JW, Fulton SP, Mudigoudar BD. Dravet Syndrome: A Review of Current Management. Pediatr Neurol . 2020;107:28-40.
Lechuga L, Franz DN. Everolimus as adjunctive therapy for tuberous sclerosis complex-associated partial-onset seizures. Expert Rev Neurother. 2019;19:913-925.
Scheffer IE, Berkovic S, Capovilla G, et al. ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology. Epilepsia. 2017;58:512-521.
Granata T, Fusco L, Gobbi G, et al. Experience with immunomodulatory treatments in Rasmussen's encephalitis. Neurology. 2003;61:1807-10.
Pearl PL, Carrazana EJ, Holmes GL. The Landau-Kleffner Syndrome. Epilepsy currents. 2001;1:39-45.
Go CY, Mackay MT, Weiss SK, et al. Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology. 2012;78:1974-80.
Mehta V, Ferrie CD, Cross JH, Vadlamani G. Corticosteroids including ACTH for childhood epilepsy other than epileptic spasms. Cochrane Database Syst Rev. 2015;2015:Cd005222.
Geng J, Dong J, Li Y, et al. Intravenous immunoglobulins for epilepsy. Cochrane Database. Syst Rev 2019;12:Cd008557.
Verrotti A, Iapadre G, Di Francesco L, Zagaroli L, Farello G. Diet in the Treatment of Epilepsy: What We Know So Far. Nutrients. 2020;12.
Neal EG, Chaffe H, Schwartz RH, et al. The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial. Lancet Neurol. 2008;7:500-6.
Lefevre F, Aronson N. Ketogenic diet for the treatment of refractory epilepsy in children: A systematic review of efficacy. Pediatrics. 2000;105:E46.
Rudy L, Carmen R, Daniel R, Artemio R, Moisés RO. Anticonvulsant mechanisms of the ketogenic diet and caloric restriction. Epilepsy Res. 2020;168:106499.
Boison D. New insights into the mechanisms of the ketogenic diet. Curr Opin Neurol. 2017;30:187-192.
Hartman AL. Does the effectiveness of the ketogenic diet in different epilepsies yield insights into its mechanisms? Epilepsia. 2008;49 Suppl 8:53-6.
Widjaja E, Jain P, Demoe L, Guttmann A, Tomlinson G, Sander B. Seizure outcome of pediatric epilepsy surgery: Systematic review and meta-analyses. Neurology. 2020;94:311-321.
Englot DJ, Rolston JD, Wang DD, Sun PP, Chang EF, Auguste KI. Seizure outcomes after temporal lobectomy in pediatric patients. J Neurosurg Pediatr. 2013;12:134-41.
Griessenauer CJ, Salam S, Hendrix P, et al. Hemispherectomy for treatment of refractory epilepsy in the pediatric age group: a systematic review. J Neurosurg Pediatr. 2015;15:34-44.
Petrik S, San Antonio-Arce V, Steinhoff BJ, et al. Epilepsy surgery: Late seizure recurrence after initial complete seizure freedom. Epilepsia. 2021;62:1092-1104.
de Tisi J, Bell GS, Peacock JL, et al. The long-term outcome of adult epilepsy surgery, patterns of seizure remission, and relapse: a cohort study. Lancet. 2011;378:1388-95.
Edelvik A, Rydenhag B, Olsson I, et al. Long-term outcomes of epilepsy surgery in Sweden: a national prospective and longitudinal study. Neurology. 2013;81:1244-1251.
Ryvlin P, Cross JH, Rheims S. Epilepsy surgery in children and adults. Lancet Neurol. 2014;13:1114-1126.
Blumcke I, Spreafico R, Haaker G, et al. Histopathological Findings in Brain Tissue Obtained during Epilepsy Surgery. New England Journal of Medicine. 2017;377:1648-1656.
Fauser S, Essang C, Altenmuller DM, et al. Long-term seizure outcome in 211 patients with focal cortical dysplasia. Epilepsia. 2015;56:66-76.
Phi JH, Cho BK, Wang KC, et al. Longitudinal analyses of the surgical outcomes of pediatric epilepsy patients with focal cortical dysplasia. J Neurosurg Pediatr. 2010;6:49-56.
Jin B, Wang J, Zhou J, Wang S, Guan Y, Chen S. A longitudinal study of surgical outcome of pharmacoresistant epilepsy caused by focal cortical dysplasia. J Neurol 2016;263:2403-2410.
Boshuisen K, van Schooneveld MM, Uiterwaal CS, et al. Intelligence quotient improves after antiepileptic drug withdrawal following pediatric epilepsy surgery. Ann Neurol. 2015;78:104-14.
Braun KPJ, Cross JH. Pediatric epilepsy surgery: the earlier the better. Expert Rev Neurother. 2018;18:261-263.
Cross JH, Jayakar P, Nordli D, et al. Proposed criteria for referral and evaluation of children for epilepsy surgery: recommendations of the Subcommission for Pediatric Epilepsy Surgery. Epilepsia. 2006;47:952-9.
Gonzalez-Martinez JA, Chauvel P. The Stereoelectroencephalography Methodology Applied to Epilepsies with a Visible Lesion. Neurosurg Clin N Am. 2020;31:387-394.
Barba C, Cross JH, Braun K, et al. Trends in pediatric epilepsy surgery in Europe between 2008 and 2015: Country-, center-, and age-specific variation. Epilepsia. 2020;61:216-227.
Abel TJ, Varela Osorio R, Amorim-Leite R, et al. Frameless robot-assisted stereoelectroencephalography in children: technical aspects and comparison with Talairach frame technique. J Neurosurg Pediatr. 2018;22:37-46.
McGovern RA, Knight EP, Gupta A, et al. Robot-assisted stereoelectroencephalography in children. J Neurosurg Pediatr. 2018;23:288-296.
Shah AK, Mittal S. Invasive electroencephalography monitoring: Indications and presurgical planning. Ann Indian Acad Neurol. 2014;17:S89-94.
Taussig D, Chipaux M, Fohlen M, et al. Invasive evaluation in children (SEEG vs subdural grids). Seizure. 2020;77:43-51.
Jayakar A, Bolton J. Pediatric epilepsy surgery. Curr Neurol Neurosci Rep 2015;15:31.
Bandt SK, Leuthardt EC. Minimally Invasive Neurosurgery for Epilepsy Using Stereotactic MRI Guidance. Neurosurg Clin N Am. 2016;27:51-8.
Quigg M, Harden C. Minimally invasive techniques for epilepsy surgery: stereotactic radiosurgery and other technologies. J Neurosurg. 2014;121 Suppl:232-40.
Brown MG, Drees C, Nagae LM, Thompson JA, Ojemann S, Abosch A. Curative and palliative MRI-guided laser ablation for drug-resistant epilepsy. J Neurol Neurosurg Psychiatry. 2018;89:425-433.
Hoppe C, Witt JA, Helmstaedter C, Gasser T, Vatter H, Elger CE. Laser interstitial thermotherapy (LiTT) in epilepsy surgery. Seizure. 2017;48:45-52.
Hoppe C, Helmstaedter C. Laser interstitial thermotherapy (LiTT) in pediatric epilepsy surgery. Seizure. 2020;77:69-75.
Fauser S, Zentner J. Critical review of palliative surgical techniques for intractable epilepsy. Adv Tech Stand Neurosurg. 2012;39:165-94.
Smyth MD, Vellimana AK, Asano E, Sood S. Corpus callosotomy—Open and endoscopic surgical techniques. Epilepsia. 2017;58:73-79.
Benifla M, Otsubo H, Ochi A, Snead OC, 3rd, Rutka JT. Multiple subpial transections in pediatric epilepsy: indications and outcomes. Childs Nerv Syst. 2006;22:992-8.
Rolston JD, Deng H, Wang DD, Englot DJ, Chang EF. Multiple Subpial Transections for Medically Refractory Epilepsy: A Disaggregated Review of Patient-Level Data. Neurosurgery. 2018;82:613-620.
Boon P, De Cock E, Mertens A, Trinka E. Neurostimulation for drug-resistant epilepsy: a systematic review of clinical evidence for efficacy, safety, contraindications and predictors for response. Curr Opin Neurol. 2018;31:198-210.
Starnes K, Miller K, Wong-Kisiel L, Lundstrom BN. A Review of Neurostimulation for Epilepsy in Pediatrics. Brain Sci. 2019;9.
Krahl SE, Clark KB. Vagus nerve stimulation for epilepsy: A review of central mechanisms. Surgical neurology international . 2012;3:S255-S259.
Klinkenberg S, Aalbers MW, Vles JS, et al. Vagus nerve stimulation in children with intractable epilepsy: a randomized controlled trial. Dev Med Child Neurol. 2012;54:855-61.
Yalnizoglu D, Ardicli D, Bilginer B, et al. Long-term effects of vagus nerve stimulation in refractory pediatric epilepsy: A single-center experience. Epilepsy Behav. 2020;110:107147.
Jain P, Arya R. Vagus Nerve Stimulation and Seizure Outcomes in Pediatric Refractory Epilepsy: Systematic Review and Meta-Analysis. Neurology. 2021.
